Literature DB >> 28317530

Depigmentation Therapies for Vitiligo.

Pearl E Grimes1, Rama Nashawati2.   

Abstract

The general goals of medical management of vitiligo are to repigment vitiliginous areas of skin and to stabilize the progression of depigmentation. However, for some patients with vitiligo affecting extensive body surface areas who are unresponsive to repigmentation therapies, depigmentation of the remaining normal skin may be a better choice. Candidates for depigmentation therapy should be carefully screened and patient education is essential. Permanent topical therapies used for depigmentation include monobenzyl ether of hydroquinone, 4-methoxyphenol, and 88% phenol. Physical modalities, such as cryotherapy and lasers, are also being used successfully.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-Methoxyphenol; Depigmentation; Disorders of appearance; MBEH; Mequinol; Monobenzyl ether of hydroquinone; Pigmentary disorders; Vitiligo

Mesh:

Substances:

Year:  2017        PMID: 28317530     DOI: 10.1016/j.det.2016.11.010

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

Review 1.  Advances in vitiligo: Update on therapeutic targets.

Authors:  Yifei Feng; Yan Lu
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

Review 2.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

3.  Use of the 532-nm Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of recalcitrant repigmentation in vitiligo.

Authors:  Krishna Modi; Tasneem F Mohammad; Iltefat H Hamzavi
Journal:  JAAD Case Rep       Date:  2018-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.